Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.

Redjal, Navid; Nahed, Brian V; Dietrich, Jorg; Kalkanis, Steven N; Olson, Jeffrey J

Redjal, Navid; Nahed, Brian V; Dietrich, Jorg; Kalkanis, Steven N; Olson, Jeffrey J.

Affiliation

Redjal N; Department of Neurosurgery, Capital Health Institute for Neurosciences, Capital Health Institute for Neurosciences, Two Capital Way, Pennington, NJ, 08534, USA. nredjal@capitalhealth.org.
Nahed BV; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Dietrich J; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Kalkanis SN; Department of Neurosurgery, Henry Ford Health System, Detroit, MI, USA.
Olson JJ; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.

J Neurooncol ; 150(2): 165-213, 2020 Nov.

Article in En | MEDLINE | ID: mdl-33215343

Subject(s)
Key words

Bevacizumab; Brain tumors; Chemotherapy; GBM; Gliomas; Temozolomide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Practice Guidelines as Topic / Glioblastoma / Angiogenesis Inhibitors / Evidence-Based Practice Type of study: Diagnostic_studies / Guideline / Systematic_reviews Limits: Adult / Humans Language: En Journal: J Neurooncol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google